{
    "Trade/Device Name(s)": [
        "Multichem WBT"
    ],
    "Submitter Information": "Technopath",
    "510(k) Number": "K132174",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072721"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "September 20, 2013",
    "Summary Letter Received Date": "August 19, 2013",
    "Submission Date": "August 16, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Cyclosporine",
        "Sirolimus",
        "Tacrolimus"
    ],
    "Specimen Type(s)": [
        "Processed human whole blood hemolysate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abbott ARCHITECT i2000"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Multichem WBT whole blood control material for monitoring precision of laboratory testing procedures for immunosuppressant drugs",
    "Indications for Use Summary": "Intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for cyclosporine, sirolimus, and tacrolimus using human whole blood.",
    "fda_folder": "Toxicology"
}